Includes any costs paid by an enrollee or on behalf of the enrollee by a third party when calculating an enrollee's overall contribution to any out-of-pocket maximum or cost sharing requirement under a health plan as of January 1, 2025.
Includes any costs paid by an enrollee or on behalf of the enrollee by a third party when calculating an enrollee's overall contribution to any out-of-pocket maximum or cost sharing requirement under a health plan as of January 1, 2025.
Requires every individual or group health insurance contract effective on or after January 1, 2025, to provide coverage to the insured and the insured's spouse and dependents for all FDA-approved contraceptive drugs, devices and other products.
Requires every individual or group health insurance contract effective on or after January 1, 2025, to provide coverage to the insured and the insured's spouse and dependents for all FDA-approved contraceptive drugs, devices and other products.
Prohibits prior authorization or a step therapy protocol for the prescription of a nonpreferred medication on their drug formulary used to assess or treat an enrollee's bipolar disorder, schizophrenia or schizotypal.
Creates the Rhode Island Individual Market Affordability Act of 2024 to help reduce out-of-pocket costs for low- and moderate-income consumers enrolled in the health insurance exchanges.
Creates the Rhode Island Individual Market Affordability Act of 2024 to help reduce out-of-pocket costs for low- and moderate-income consumers enrolled in the health insurance exchanges.
Prohibits any health insurer, pharmacy benefit manager, or other third-party payor from discriminating against any 340B entity participating in a drug discount program.
Requires a report to be produced that focuses on prescription drug prior authorizations by January 1, 2025.
Requires a report to be produced that focuses on prescription drug prior authorizations by January 1, 2025.